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Grafting alopecia areata a¡ected C3H/HeJ mouse skin
to littermates induces alopecia areata, but high dietary
soy oil reduces alopecia areata susceptibility. Alopecia
areata a¡ected and resistant mice were characterized
to evaluate possible mechanisms involved in alopecia
areata resistance. Of 44 mice that received alopecia
areata a¡ected skin grafts but failed to develop alopecia
areata, only two of 22 receiving further alopecia areata
a¡ected skin grafts developed alopecia areata, whereas
39 of 44 controls developed alopecia areata. Alopecia
areata a¡ected skin contained increased numbers of
CD4þ and CD8þ cells, increases in pro in£ammatory
T helper 1 and T helper 2 type cytokines, and upregula-
tion of CD28, CD40L, and their ligands. In draining
lymph nodes, a relatively high number of antigen-pre-
senting cells was recovered, whereas several CD44v var-
iants were downregulated. In contrast, alopecia areata
resistant mouse skin did not display increased numbers
of CD4þ and CD8þ cells, whereas counter-regulatory
cytokines interleukins 4 and 10 were upregulated. High
expression of CD28, CD80, CD86, CD40, CTLA4,
CD44v variants, and FasL occurred in alopecia areata
resistant mouse spleens. In vitro, lymph node cells of
susceptible and resistant mice responded equally to a
mitogenic stimulus, but only lymph node cells from
alopecia areata a¡ected mice displayed an increased re-
sponse with T cell receptor stimulation via anti-CD3
cross-linking. These results suggest alopecia areata is a
cell-mediated autoimmune disease, but alopecia areata
a¡ected skin graft hosts may resist alopecia areata onset
through active counter-regulatory mechanisms. Be-
cause alopecia areata resistant mice showed unimpaired
responsiveness and a transient in£ammatory response
towards the graft, it is suggested that alopecia areata de-
velops as a consequence of an inappropriate immune
response regulation. Key words: autoimmune diseases/dis-
ease models/immune tolerance/in£ammation. J Invest Derma-
tol 119:1426 ^1433, 2002
A
lopecia areata (AA) is a suspected autoimmune dis-
ease involving focal perifollicular and intrafollicular
in£ammation of anagen stage hair follicles. Several
rodent strains have been identi¢ed as animal models
for AA of which the long-standing C3H/HeJ inbred
mouse strain has been characterized in greatest detail (Sundberg
et al, 1994; McElwee et al, 1998a, 1999a,b; Freyschmidt-Paul et al,
1999). Breeding studies indicate that AA in mice is a polygenic
disease with partial phenotype penetrance where only 20% of
aging C3H/HeJ mice spontaneously develop AA (Sundberg et al,
1994; McElwee et al, 2001). The AA phenotype, however, can be
transferred from spontaneously a¡ected mice to normal-haired
recipients of the same or histocompatible strain by skin grafts or
subcutaneous injection of lymph node or spleen cells (McElwee
et al, 1998b; Carroll et al, 2002). Previous studies have demon-
strated signi¢cant, proin£ammatory immune cell activity prior
to the onset of hair loss in skin graft induced AA (Z˛ller et al,
2002). These and other experiments suggest rodent and human
AA involve cell-mediated in£ammatory disease mechanisms
(McElwee et al, 1999b).
The ability to transfer an in£ammatory autoimmune pheno-
type between a¡ected and una¡ected individuals using immune
system derived cells has been demonstrated in other rodent auto-
immune disease models (Bernard et al, 1976; Braley-Mullen et al,
1985; Wicker et al, 1986; Karussis et al, 1999; Ludewig et al, 1999).
Equally, resistance to autoimmune disease induction has been de-
monstrated by transfer of conditioned immune system derived
cell subsets or clones prior to the disease activation event (Ber-
nard, 1977; Reich et al, 1989; Itoh et al, 1991; Hutchings et al, 1993;
Feili-Hariri et al, 1999). Tolerance to alloantigens and resistance to
autoimmune disease has also been promoted in rodent models
by exposure to antigenic material under speci¢c conditions
(Halliday and Muller, 1986; Zhang et al, 1991; Strobel and Mowat,
1998; Anderton et al, 1999;Woods et al, 2000). Similarly, if AA in
C3H/HeJ mice is an autoimmune disease with mechanisms of
development equivalent to those observed in other autoimmune
disease models, it may be possible to promote resistance to the
onset of AA by transfer of immune system components and/or
hair follicle antigenic material to naive mice prior to an AA
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activation event. Ability to induce resistance to AA in genetically
susceptible mice, and characterization of the mechanisms in-
volved in resistance, may de¢ne potential mechanisms to be
exploited in new therapeutic approaches.
AA is likely to be a complex, multifactorial disease where both
genes and the environment play a part in AA susceptibility
(McElwee et al, 1999b, 2001). Recently, dietary soy oil content
has been identi¢ed as a key factor that can reduce susceptibility
to skin graft induced AA onset in mice (McElwee et al, in press).
Increased soy oil content in laboratory diets was associated with
increased failure to induce AA by use of the previously described
skin graft technique (McElwee et al, 1998b). In pilot studies, mice
that failed to develop AA after initial skin grafting and subse-
quently fed a low soy oil diet would not develop AA even with
repeated skin grafting. To evaluate whether this observation
re£ected a state of anergy or was based on counter-regulatory
mechanisms, mice were repeatedly grafted with AA-a¡ected skin
and immune response parameters, including activation markers,
adhesion molecules, and cytokine expression pro¢les, were tested
locally and systemically. Functional studies to examine the
response of cells from AA-a¡ected and AA-resistant mice in vitro
were conducted.
MATERIALS AND METHODS
Susceptible and resistant mice and surgical procedure All C3H/HeJ
mice were supplied from stocks at the Jackson Laboratory (Bar Harbor,
ME) speci¢c pathogen-free production facility. All mice were housed in
separate cages in isolation in a single room at the University of Marburg
and received acidi¢ed water (pH 2.8^3.0) ad libitum for the duration of the
study. All experiments were conducted in accordance with the German
code of practice for the care and use of animals for scienti¢c purposes and
with approval from the Philipp University Animal Ethics Committee. In
multiple, routine surgical sessions, where mice received a diet with a higher
soy oil content (altromin 1434, Altromin, GmBH, Lage, Germany) that is
known to reduce AA susceptibility (McElwee et al, in press), normal-haired
mice were grafted with AA-a¡ected skin using procedures as described
previously (McElwee et al, 1998b). Multiple circular sections of full
thickness skin were pinch cut from spontaneous AA-a¡ected mice and
one each grafted to normal-haired C3H/HeJ mice. After observation for
at least 15 wk, some individuals accepted their AA-a¡ected skin grafts, but
did not develop AA as was expected from conclusions based on previous
studies (McElwee et al, 1998b, in press). Subsequently, and for the duration
of the study, all mice received a low soy oil diet (altromin 1324, Altromin)
known to be more favorable for susceptibility to AA induced by skin
grafting (McElwee et al, in press).
Of 54 mice that failed to develop AA, 22 with a mean age of 23 wk at
grafting were necropsied at 46 wk of age for routine analysis and 10 mice
were maintained in isolation for long-term clinical observation. The
remaining 22 age-matched mice were maintained in isolation and
regrafted at a mean age of 46 wk with AA-a¡ected skin using the same
technique (McElwee et al, 1998b). As a control, 44 age-matched normal-
haired, previously surgically unmanipulated mice with a mean age of
23 wk were grafted using skin from the same AA-a¡ected donors. In
addition, 10 mice were sham grafted. Mice were observed for 20 wk and
any changes in pelage coat quality were recorded. A photographic record
was made where appropriate.
Mice were killed and skin was excised from mice that tolerated a single
skin graft, mice that were resistant to AA after two consecutive skin grafts,
AA-a¡ected mice, sham grafted, and normal-haired mice. Skin samples
from each mouse were ¢xed in Fekete’s acid^alcohol^formalin solution,
para⁄n embedded, sectioned at 6 mm, and stained with hematoxylin and
eosin for histologic evaluation (Relyea et al, 1999). Skin samples were
also embedded in OCT compound (Tissue Tek, Sakura, Zoeterwoude,
the Netherlands) and snap frozen in liquid nitrogen for subsequent
immunohistology.
Immunohistology Immunohistology was performed on cryostat tissue
sections as described elsewhere (Freyschmidt-Paul et al, 2000). Brie£y,
tissue alkaline phosphatase activity was ablated with levamisole solution
and nonspeci¢c binding blocked using an avidin^biotin blocking
kit (Vector Laboratories, Burlingame, CA) and 2% normal goat
serum. Cryostat sections were exposed to rat anti-mouse CD4 (clone
RM4-5, Pharmingen, San Diego, CA), CD8 (clone 53^6.7, Southern
Biotechnology, Birmingham, AL), major histocompatibility complex
(MHC) class I (Clone ER-MP 42), MHC class II (clone ER-TR 3),
macrophage cell (clone 5C6), and dendritic cell (clone NLDC-145)
speci¢c monoclonal antibodies (MoAb) (all Dianova, Hamburg,
Germany). Biotinylated goat anti-rat (Dianova) and alkaline phosphatase
conjugated avidin^biotin complex (Vector) solutions were applied in
sequence and tissue sections counter stained with Mayer’s hematoxylin.
The primary monoclonal antibody was replaced with normal rat IgG for
negative controls. Positive controls were derived from lymph node and
spleen tissues. Immunohistology using the same tissues was replicated on
¢ve separate occasions using tissues from 10 normal-haired mice, 12 AA-
a¡ected mice, 22 mice with failed AA induction grafted once, and 22
mice resistant to AA induction grafted twice as described above.
Flow cytometry Flow cytometry analyses were conducted on the entire
dorsal and ventral skin, draining lymph nodes (axillary, brachial, super¢cial
cervical, inguinal), and spleen. Tissues were taken from 11 normal-haired
mice, 11 age-matched sham-grafted mice 3 wk postsurgery, 11 mice with
skin graft induced AA 15 wk postsurgery, eight age-matched mice with
tolerance to a single skin graft 15 wk postsurgery, and 12 mice with
resistance to AA onset after two consecutive skin grafts with surgeries
conducted 17 wk apart and necropsy 3 wk after the second surgical
procedure. In each analysis, the lymph node and spleen cells of each
mouse were tested individually, whereas the skin derived leukocytes were
pooled from two or three mice in each group and processed
simultaneously due to the low numbers of cells obtained from skin
processing.
Single leukocyte cell suspensions were prepared by pressing lymph
nodes and spleens through ¢ne gauze. After removing fat and
subcutaneous muscle tissue, skin was laid epidermis uppermost on sterile
gauze. Skin was then covered with 25 ml of a solution of 1% trypsin, 50
U per ml collagenase, and 27 U per ml DNase (Sigma, Deisenhofen,
Germany), and incubated three times 30 min. After each incubation, the
skin was pressed against the sterile gauze and the isolated cells were
collected in RPMI 1640 medium containing 10% fetal bovine serum
(Gibco BRL, Gaithersburg, MD). After the ¢nal trypsin treatment, cells
were pooled, washed, and resuspended in RPMI 1640 containing 10%
fetal bovine serum plus 10^3 M HEPES bu¡er. The cells were incubated at
371C, 5% CO2 in a humidi¢ed atmosphere for 2 h for the recovery of cell
surface molecule expression. After determining viable cell concentration
by exclusion of 0.1% trypan blue (Sigma), cell samples were diluted to
1^5106 cells per ml. For the determination of intracellular cytokines,
cells were ¢xed and permeabilized before incubation with MoAb.
Each cell sample was aliquoted and incubated with 10 mg per ml of the
following MoAb: unconjugated anti-mouse CD4 (clone YTA 3.2.1), CD8
(clone YTS 169.4.2.1), macrophage (clone YBM 6.6.10), ICAM-1 (clone
YN1/1.7.4) (all EACC, Porton Down, U.K.); LFA-1 (clone M17/5.2),
dendritic cell (clone 33D1), and CD44s (clone IM7) (all ATCC, Manassus,
VA); biotinylated anti-mouse interleukin (IL)-2 (clone JES6^5H4), IL-4
(clone BVD6^24G2), IL-6 (clone MP5^32C11), IL-10 (clone JES3^16E3),
IL-12 (clone C17.8), interferon (IFN)-g (clone XMG1.2), and tumor
necrosis factor (TNF)-a (clone MP6-XT3); phycoerythrin-labeled
anti-mouse MoAb for CD25 (clone PC61), CD28 (clone 37.51), CD40
(clone 3/23), CD80 (clone 16^10A1), CD95 (clone Jo2), CD95L (clone
MFL3), CTLA4 (clone UC10^4F10-11), CD40L (clone MR1), and IgM
(clone R6-60.2) (all Pharmingen) were used. Unconjugated anti-mouse
CD44v3 (clone PTS33; Seiter et al, 1999), CD44v6 (clone 11A6; Seiter et al,
2000), CD44v7 (clone LN7.2; Wittig et al, 1998), CD44v10 (clone K926;
R˛sel et al, 1997), and VLA-4 (clone PS/2, kindly provided by K. Miyake;
Hession et al, 1992) were also used.
Cells incubated with unconjugated MoAb were subsequently incubated
with the appropriate anti-mouse or anti-rat phycoerythrin-labeled
secondary antibody. Cells labeled with biotinylated MoAb were detected
with streptavidin^phycoerythrin (all Pharmingen). Negative controls
were incubated with a nonbinding primary antibody and the same
secondary reagents as described. Flow cytometry followed routine
procedures. A £uorescence-activated cell sorter (Becton Dickinson,
Sunnyvale, CA) was used to analyze lymphocyte cell populations. Events
were analyzed using appropriate forward and side scatter settings and gates
de¢ning the relevant cell populations. Cell viability was assessed by
propidium iodide exclusion and keratinocytes, dead cells, and cell debris
were excluded from analysis. All experiments were repeated on at least
three separate occasions and the mean 7SD values of 10^20 analyses are
given. Flow cytometric data was analyzed by Student’s t-test for the
signi¢cance of di¡erences between normal-haired mice, as a baseline, and
all surgically manipulated mice.
Proliferation assay Skin draining lymph node cells (LNC) were
stimulated by 1 mg per ml phytohemagglutinin, a mitogen, or by 10 mg
per ml hamster anti-mouse CD3 (clone 145^2c11, Pharmingen). LNC
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(105) were suspended in 200 ml RPMI (Gibco) supplemented with 1%
mouse serum, 10^5 M 2-mercaptoethanol, and 10^3 M HEPES bu¡er, and
were seeded in triplicate in £at-bottomed 96 well plates. After 40 h
incubation at 371C, 5% CO2 cells were pulsed with
3H-thymidine (10
mCi per ml) and incubated for an additional 8 h. Cells were harvested
with an automatic harvester and 3H-thymidine incorporation was
determined in a liquid scintillation counter. Mean7 SD are presented.
RESULTS
Uncovering resistance towards AA by skin grafting Routine
full thickness skin grafts from AA-a¡ected donors was carried
out on normal-haired mice (McElwee et al, 1998b); 69 mice
developed AA and 44 mice that accepted their grafts failed to
develop hair loss. Routine histology showed all skin graft sites
had limited peripheral scarring consistent with the surgical
procedure. No apparent mononuclear cell in£ammation was
observed in or around recipient hair follicles. Repeat grafting of
22 mice that did not show any hair loss, failed to induce overt
hair loss in 20 recipients (91%). Two mice developed limited AA
at 3 and 12 wk after the second surgical procedure and persisting
until the time of necropsy. Gross observation of the remaining 20
mice from grafting until necropsy showed no overt hair loss. Ten
additional, repeat grafted mice reserved for long-term
observation showed no apparent expression of AA for over 10
mo. Thirty-nine of 44 control mice (89%) that received AA-
a¡ected skin from the same donors had developed AA by 10 wk
after surgery in the same fashion as that previously described
(Sundberg et al, 1994; McElwee et al, 1998b), with the remaining
¢ve mice having rejected their skin grafts.
Resistance towards AA is accompanied by a failure to
recruit CD4þ and CD8þ cells Normal skin containing
anagen stage hair follicles and sham-grafted skin distant from
the graft site contained isolated CD4þ cells, macrophages, and
dendritic cells with a di¡use distribution throughout the dermis,
but virtually no CD8þ cells were present (Fig 1). In contrast,
dystrophic anagen stage hair follicles of AA-a¡ected mice had
a signi¢cant perifollicular in¢ltration of CD4þ cells. Serial
sections revealed an increase in perifollicular CD8þ cells in
close association with the CD4þ cell in¢ltrate. In addition,
some CD8þ cells had penetrated to intrafollicular locations.
Hair follicles were also the focus of signi¢cant macrophage and
dendritic cell activity (Fig 1). Mice that tolerated both single
and double skin grafts and failed to develop AA all
demonstrated a di¡use in¢ltrate of monocytes and dendritic
cells (Fig 1). CD8þ cells were absent from all mice, but three
mice with failed AA development grafted twice exhibited a
di¡use CD4þ cell in¢ltrate of the upper dermis around both
anagen and telogen stage hair follicles.
As expected from published studies, MHC class I and II
expression was largely absent from hair follicles in nongrafted,
normal-haired mice except for isolated anagen and telogen stage
hair follicles presenting with MHC class II in the upper hair canal
outer root sheath (ORS) and adjacent epidermis (Fig 1). Sham-
grafted mice presented with a similar distribution of isolated
hair follicle expression distant from the skin graft site, but in
addition, hair follicles of host skin immediately adjacent to the
skin graft and scar tissue expressed MHC class II throughout the
ORS. Anagen stage hair follicles both adjacent and distant from
the graft site in AA-a¡ected mice were consistently positive for
MHC class I and class II within all areas of the ORS and
sometimes in areas of the inner root sheath. Expression on the
cells of the in£ammatory in¢ltrate was also observed. Mice that
tolerated a single skin graft and failed to develop AA
demonstrated MHC class II expression similar to nongrafted
normal-haired controls with isolated positive expression in the
upper hair canal of anagen and telogen follicles. Mice that
received two sequential skin grafts with no AA development
also had similar expression patterns distant from the grafts, but
in addition presented with MHC I and MHC II expression in
the ORS of hair follicles adjacent to the second skin graft and
scar tissue site.
Flow cytometry of leukocytes isolated from the skin
con¢rmed the immunohistologic ¢ndings. A signi¢cant increase
in the percentage of CD4þ and CD8þ T cells as well as B
(surface IgMþ ) cells was only seen in preparations of AA-
a¡ected skin. In contrast, preparations of AA-resistant mouse
skin exhibited a relative dominance of monocytes and dendritic
cells. Sham-grafted mice showed no signi¢cant changes in
the distribution of leukocyte subpopulations compared with
unmanipulated controls (Fig 2a).
Figure1. Immunohistologic appearance of normal, AA-a¡ected,
and AA-resistant mouse skin. Normal C3H/HeJ mouse skin is virtually
devoid of CD8+ cells (a) as is AA resistant skin (c), but CD8+ cells are
present in signi¢cant numbers in both perifollicular and intrafollicular lo-
cations in AA-a¡ected skin (b). Skin containing anagen stage hair follicles
from normal-haired, nonsurgically manipulated mice contain isolated
CD4+ cells (d), whereas AA-a¡ected hair follicles exhibit a moderate peri-
follicular increase in CD4+ cell numbers (e). Mice with failed AA induc-
tion after two consecutive skin grafts have skin containing CD4+ cells in
numbers similar to that observed for normal mice (f). Isolated macrophages
are present in normal-haired skin (g) and variably present in AA-a¡ected
skin with some anagen hair follicles the focus of particularly intense
macrophage activity (h). AA-resistant mouse skin also contained perifolli-
cular in¢ltrates (i). Normal-haired skin contained individual dendritic cells
(j), whereas AA-a¡ected skin revealed various degrees of dendritic cell in-
¢ltration (k) and AA-resistant mouse skin revealed a modest in¢ltration (l).
MHC class I expression was generally absent from normal-haired and AA-
resistant skin (m,o), whereas AA-a¡ected skin exhibited intense MHC class
I expression in the ORS of some hair follicles that were the focus for in-
tense in£ammatory cell activity (n). Similarly, MHC class II expression was
absent in the lower dermis of normal-haired and AA-resistant mice except
for isolated cells, likely to be dendritic cells (p,r), but AA-a¡ected hair fol-
licles and in£ammatory in¢ltrates highly expressed MHC class II (q). Bar
(a^q) ¼ 100 mm.
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Di¡erences in the activated state of skin-associated
leukocytes in AA-susceptible and AA-resistant mice The
state of skin associated leukocyte activity in sham-grafted mice
vs AA-a¡ected mice and skin-grafted mice that did not develop
AA was evaluated by analyzing the expression of costimulatory
molecules and their ligands, proin£ammatory as well as T helper
(Th)1- and Th2-associated cytokines, and adhesion molecules. As
compared with nonsurgically manipulated controls, skin-derived
leukocytes of sham-grafted mice exhibited no signi¢cant
alterations except for upregulation of IL-4 (Fig 2b). This was
expected as the analysis was performed 3 wk after sham grafting
at a time point where the syngeneic graft had been accepted
and any acute surgical stress associated changes should have
dissipated.
In mice that developed AA, both major families of
costimulatory molecules and their ligands, CD80, CD86, and
CD28 as well as CD40 (gp39 receptor) and CD40L (CD154,
gp39, Ly62), were signi¢cantly upregulated (Fig 2c). A
signi¢cant change in the regulatory costimulus CTLA4 (CD152,
Ly56) was not observed. None of these markers were upregulated
in skin-grafted mice that did not develop AA. CD95 ligand
(FasL) was signi¢cantly depressed in the skin of resistant mice
along with CTLA4.
The proin£ammatory cytokines IL-6 and TNF-a were
expressed at an increased level only in AA-a¡ected mice, but not
in AA-resistant mice (Fig 2b). Furthermore, the Th1- and Th2-
associated cytokines, IL-10 and IL-4 as well as IL-12 and IFN-g
were elevated in AA-a¡ected mice. In contrast, theTh1 regulatory
cytokine IL-10 was predominant in AA-resistant mice along with
a slight increase in IFN-g. Also of note, the proin£ammatory
cytokines IL-6, IL-12, and TNF-a were expressed within the
normal range in AA-resistant mice.
Particular attention was paid to CD44 as the standard isoform
of CD44 (CD44s) is known to be important for leukocyte
extravasation. In addition, we have previously shown that anti-
CD44v10 MoAb blocked immunocyte in¢ltration and onset of
AA (Freyschmidt-Paul et al, 2000). In AA-a¡ected skin, pan-
CD44 as well as the leukocyte-associated CD44v6 were sharply
upregulated (Fig 2d). Expression of CD44v7, commonly
associated with chronic in£ammation of the gut (Wittig
et al, 1998), was una¡ected. A similar pro¢le was observed for
CD44v10. Expression of CD44v3, which is typically
upregulated in most autoimmune skin diseases, was signi¢cantly
downregulated in AA-a¡ected skin consistent with previous
studies (Z˛ller et al, 2002). Expression levels of the CD44
standard and variant isoforms in AA-resistant mice were
unaltered as compared with controls. As may have been
anticipated, LFA1 was upregulated in all surgically manipulated
mice without any distinct pattern.
Susceptibility towards the development of AAwas re£ected by
the activated state of leukocytes in draining lymph nodes. The
most prominent feature of the enlarged draining lymph nodes
in AA-a¡ected mice was the signi¢cant number of monocytes
and dendritic cells that were accompanied by high levels of IL-6
andTNF-a expression. Both features circumstantially suggested a
continuing transfer of antigen presenting cells from the skin
towards the node. With the exception of a downregulation of
CTLA4 and a slight upregulation of CD80, expression of
costimulatory molecules and their ligands was largely unaltered.
Expression of Th1 cytokines was also largely una¡ected, whereas
expression of Th2 cytokines, primarily IL-4 and to a lesser extent
IL-10, was high. With respect to CD44 isoforms, CD44v3 was
low, as was observed in the skin. Expression of CD44s, CD44v7
and CD44v10, which were unaltered in the skin, were
downregulated in the draining lymph nodes, whereas expression
of CD44v6 was una¡ected. In AA resistant mice these changes
were not observed. TNF-a, sIgM and, probably due
to the high numbers of sIgMþ cells, CD80 were increased
(Fig 3a^d).
These features pointed towards an inappropriate chronicity of
response in AA-susceptible mice rather than towards a state of
Figure 2. Flow cytometric analysis of skin-derived cells. A signi¢-
cant increase in CD4+, CD8+, and sIgM+ cells in AA-a¡ected skin con-
trasted with signi¢cant increases in macrophages and dendritic cells for
mice with failed AA after one or two consecutive grafts (a).Whereas AA-
a¡ected mice demonstrated increased expression in all cytokines evaluated,
mice with resistance to AA had signi¢cant increases in cytokines IL-4 and
IL-10 but no increase in proin£ammatory cytokines, IL-6 and IL-12 (b).
AA-a¡ected mice exhibited signi¢cant increases in costimulation mole-
cules CD28, CD40, CD80, and CD86 (c) and increased expression of
CD44v6 (d). The mean7SD of 10^20 analyses are given. Filled shapes in-
dicate signi¢cant increased or decreased frequency of expression (po 0.01)
in surgically manipulated mice vs normal-haired mice, open shapes indicate
no signi¢cant di¡erence.
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anergy in AA-resistant mice.The analysis of a mitogenic response
as well as a polyclonal response induced by cross-linking of CD3
con¢rmed the hypothesis (Table I). Whereas draining LNC of
AA-resistant mice displayed an unimpaired response as
compared with controls, the response of AA-a¡ected mice
towards cross-linking of the T cell receptor was signi¢cantly
increased. Notably all three groups responded equally well to a
mitogenic stimulus (phytohemagglutinin). It also should be
mentioned that the cellular constitution of draining LNC
di¡ered signi¢cantly between AA-a¡ected and AA-resistant
mice. A mean of 14.810671.1106 LNC were collected from
AA-a¡ected mice, whereas a mean of 6.610670.7106 and
5.410670.4106 cells were recovered from AA-resistant and
control mice, respectively. The di¡erence between AA-a¡ected
and control mice being highly signi¢cant (po 0.001).
It is of note that at the systemic level of the spleen, the
downregulation of CD44 variant isoforms was not generally
observed in AA-susceptible mice, whereas AA-resistant mice
exhibited signi¢cant increases in CD44v3, CD44v6, CD44v7,
and CD44v10. Furthermore, the costimulatory molecules and
their ligands, CD28, CD80, CD86, and CD40, were high in
AA-resistant mice in contrast to depressed expression in AA-
a¡ected mice. Whereas AA-a¡ected mice demonstrated a
reduction in CD95 and CTLA4, AA-resistant mice had increases
in CD95L and CTLA4. Overall, cytokine expression was not
signi¢cantly a¡ected (Fig 4a^d).
Taken together, there was evidence for skin in¢ltration of
activated T cells in AA-a¡ected mice. In the AA-resistant mice
evidence points mainly towards downregulation of a primary
response to the AA-a¡ected skin transplant. In AA-susceptible
mice the in£ammatory response becomes chronic.
DISCUSSION
The etiology of AA has not yet been unequivocally de¢ned;
however, there is increasing evidence for AA being an autoim-
mune disease (McElwee et al, 1999b). Here we show that failure
to induce AA in normal-haired mice by grafting skin from AA-
a¡ected mice is accompanied by a general resistance to future AA
development.
The activated state of di¡erent leukocyte cell subsets in AA-af-
fected mouse skin supports the notion that AA is an autoimmune
disease. Healthy anagen stage hair follicles are believed to be tran-
sient immune privileged sites where MHC class I and II antigen
expression is generally absent. In contrast, MHC antigens are
highly expressed in AA-a¡ected follicles (Messenger and Bleehan,
1985; Br˛cker et al, 1987; Paus et al, 1993, 1999; Gilhar et al, 1998,
2001). After the transfer of AA-a¡ected skin, anagen hair follicles
and the associated in£ammatory cells only in the AA-susceptible
mouse skin expressed MHC class I and II molecules, whereas hair
follicles in normal-haired mice and AA-resistant mice lacked
MHC antigens. Expression of MHC class I and class II may allow
direct presentation of hair follicle speci¢c ‘‘self ’’antigens that have
not previously been encountered by the immune system. This
Figure 3. Flow cytometric analysis of lymph node derived cells.
Mice with AA had a high percentage of macrophages and dendritic cells
present in draining lymph nodes (a) and high expression of antigen-pre-
senting cell associated cytokine IL-6 (b). Limited changes in cell surface
molecule expression was apparent (c), but AA-a¡ected mice demonstrated
reduced cellular expression of migratory associated molecules pan CD44,
CD44v3, CD44v7, and CD44v10 (d). The mean7SD of 10^20 analyses
are given. Filled shapes indicate signi¢cant increased or decreased fre-
quency of expression (po 0.01) in surgically manipulated mice vs normal-
haired mice, open shapes indicate no signi¢cant di¡erence.
Table I. Proliferative activity of skin draining LNC provides
no evidence for anergy and supports active repression of
alopecia areata in resistant mice
CPM/105 LNC (p-value)
LNC source Phytohemagglutinina Anti-CD3b
Normal-haired 186.74374.63 374.45475.61
C3H/HeJ mice
AA-a¡ected mice 184.23073.92 (NS) 552.43375.99 (o 0.001)
AA-resistant mice 182.75574.0 (NS) 391.16976.77 (NS)
a1 mg per ml.
bPlates were coated with 10 mg NOAb per ml.
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scenario is supported by the immune system’s prior ignorance of
anagen hair follicle antigens due to the absence of MHC mole-
cules, and is frequently described in organ-speci¢c autoimmune
diseases (Smith and Allen, 1992; Jemison et al, 1993; Kuhr et al,
1994). By expression of MHC class I and II antigens in anagen
hair follicles of the host, the persistent, although inappropriate,
presentation of self antigens could support the perpetuation of
chronic AA; however, the induction of injury in sham-grafted
mice and the subsequent transient increase in MHC promoting
cytokine TNF-a in the skin and expression of MHC class I and
II at the junction of the graft and host tissue is in itself not en-
ough to promote onset of AA. Other factors beyond MHC class
I and II expression must be required for disease induction and
likely involve appropriate antigen presentation in association with
costimulatory action.
Most notably, and in line with an autoimmune hypothesis for
AA, both costimulatory factors CD86 and CD80 were signi¢-
cantly upregulated in the skin and CD80 was signi¢cantly upre-
gulated in the lymph nodes of mice with AA as compared with
control and resistant mice. Also called B7-2 and B7-1, respec-
tively, these molecules are expressed on antigen-presenting cells
and costimulate lymphocytes in association with antigen presen-
tation (Razi-Wolf et al, 1992; Galvin et al, 1992; Freeman et al, 1993;
Hathcock et al, 1994). The CD80 and CD86 ligand CD28, nor-
mally expressed on mature T cells and natural killer cells (Hard-
ing et al, 1992; Gross et al, 1992), was also signi¢cantly upregulated
in AA-a¡ected mice. The importance of costimulatory molecules
in AA pathogenesis was recently con¢rmed using speci¢c anti-
CD80 or anti-CD86 MoAb to inhibit onset of AA induced by
skin grafting (Carroll et al, 2002).We suggest that the high level
of costimulatory molecules may well support the perpetuation of
response in AA-susceptible mice, but would also argue that the
level of costimulatory molecules in AA-resistant mice had re-
turned towards base levels at 3 wk after grafting, i.e., the response
toward the AA-a¡ected skin graft was actively downregulated.
Organ-speci¢c autoimmune diseases are frequently based on
the activation of autoreactive Th1 cells, which may be accompa-
nied by the activation of autoreactive, cytotoxic lymphocytes.
Previously, cytokines IL-1b, IL-2, and IFN-g were de¢ned as
upregulated in human AA-a¡ected skin (Ho¡mann et al, 1994).
The cytokine expression pro¢le did not de¢ne an unequivocal
Th1 vs Th2 cytokine dominated state in AA-a¡ected mice, thus
con¢rming previous observations (Z˛ller et al, 2002). The mono-
cyte-derived in£ammatory cytokines TNF-a and IL-6 were
expressed at an elevated level. Increased expression of Th1
cytokines IL-12 and IFN-g as well as Th2 cytokines IL-4 and
IL-10 were also observed; however, taking into account the rela-
tively high percentage of CD4þ and CD8þ cells present, IFN-g
was the dominant upregulated cytokine. Considering AA can be
transferred by leukocytes and skin grafts, a Th1-based autoim-
mune mechanism is most likely.
There were major di¡erences in the distribution of leukocytes
and their activated state in AA-resistant mice vs AA-a¡ected mice.
The skin of AA-resistant mice did not show any signi¢cant in¢l-
tration of lymphocytes. Thus, the relative percentage of mono-
cytes and dendritic cells was strongly increased. In the absence
of CD8þ cells, it is likely that the IFN-g expressed was also
monocyte derived. Interestingly, there was an increase in regula-
tory cytokines IL-4 and IL-10, but no change in proin£amma-
tory cytokines IL-6 and TNF-a. Thus, antigen-presenting cells
did not become fully activated and the fewRprobably resi-
dentRT cells in the skin of AA-resistant mice appeared to be of
a regulatory phenotype. Interestingly, the opposite phenomenon
was observed during AA development where disease onset was
associated with a lack of CD4þ/CD25þ regulatory cells (Z˛ller
et al, 2002). Furthermore, the number of draining LNC was not
signi¢cantly increased in AA-resistant mice and neither activation
markers nor costimulatory molecules and their ligands were up-
regulated.
Previous studies have shown that CD44 variant isoform
expression is important for leukocyte migration and activation
Figure 4. Flow cytometric analysis of spleen-derived cells. Mice re-
sistant to AA development revealed signi¢cant increases in macrophages
and dendritic cells and a modest increase in sIgM+ cells in the spleen (a).
Limited changes in cytokine expression were observed (b), but increased
expression of CD28, CD80, CD86, and CD40 in AA-resistant mice di-
rectly contrasted with depressed expression of the CD25, CD28, CD40L,
and CD80 in AA-a¡ected mice (c). A direct contrast in increased expression
of CD44v7 in AA-resistant mice compared with depression in AA-a¡ected
mice was also observed (d). The mean7SD of 10^20 analyses are given.
Filled shapes indicate signi¢cant increased or decreased frequency of ex-
pression (po 0.01) in surgically manipulated mice vs normal-haired mice,
open shapes indicate no signi¢cant di¡erence.
ALOPECIA AREATA AND DISEASE RESISTANCE IN MICE 1431VOL. 119, NO. 6 DECEMBER 2002
in several autoimmune disease models (Z˛ller, 2001). CD44s has
been described as a major factor required for lymphocyte extra-
vasation (DeGrendele et al, 1997). CD44v3 and CD44v10 were
shown to be important for lymphocyte and monocyte extravasa-
tion, respectively (R˛sel et al, 1997; Seiter et al, 1999). Surprisingly,
in the skin of AA-a¡ected mice, CD44v3 was downregulated and
in the draining lymph nodes expression of CD44s, CD44v3,
CD44v7, and CD44v10 was decreased. In contrast, upregulation
of CD44s, CD44v3, and CD44v10 in the spleens of resistant mice
was observed. The comparatively high level of CD44 variant iso-
form expression in the spleen of AA-resistant mice would be in
line with the interpretation that resistance is due to the activation
of regulatoryT cells rather than to tolerance.
Binding of Fas (CD95) by Fas L (CD95L) induces apoptosis of
the Fas-expressing cells. This is one mechanism by which
in£ammatory cells may act in mouse AA to induce hair follicle
disruption (Freyschmidt-Paul et al in press); however, Fas and
FasL are also a receptor^ligand pair signi¢cantly involved in
lymphocyte homeostasis and peripheral immune system toler-
ance through activation-induced cell death (AICD) (van Parijs
and Abbas, 1996; Sabelko-Downes and Russell, 2000). Leukocytes
in the spleens of AA-resistant mice exhibited an activated
state with expression of CD40, CD28, CD80, and CD86.The in-
crease of FasL expression in these activated leukocytes may re£ect
an increase in AICD. Depression of Fas expression on leukocytes
derived from the skin and spleens of AA-a¡ected mice may
indicate a failure in AICD of autoreactive lymphocytes in these
mice. The induction of lymphocyte cell anergy is dependent
on the recognition of CD80 and CD86 costimulators
by the inhibitory lymphocyte cell receptor, CTLA4 (June et al,
1994; Lane, 1997). There was a signi¢cant increase in CTLA4
expression in the leukocytes derived from AA-resistant
mouse spleens of repeatedly grafted mice, whereas in
contrast, spleen leukocytes from AA-a¡ected mice demonstrated
a reduction in CTLA4. Lymphocyte anergy and AICD
may be mechanisms by which mice can resist AA development
and the spleen may be a key focus for immune tolerance
promotion.
Taking into account that AA-susceptible and AA-resistant
mice received skin transplants from the same mice, it can be con-
cluded that the transfer of autoreactiveTcells can su⁄ce to induce
autoreactivity in the healthy recipient. This raises the question,
why some mice consistently do not develop AA. Are they resis-
tant a priori or do they develop counter-regulatory mechanisms?
Some features, such as the increased expression rate of costimula-
tory molecules and their ligands in the spleens of AA-resistant
mice, as well as the high expression level of the regulatory cyto-
kine IL-10, point towards active counter-regulation and control-
ling of an autoimmune reaction rather than towards tolerance
through ignorance. The fact that LNC of AA-resistant mice re-
spond unimpaired to T cell receptor cross-linking also argues
against anergy in AA-resistant mice and supports a hypothesis of
active downregulation in the immune response, whereas LNC
from AA-a¡ected mice are reactive due to a failure of immune
response regulation.
Taken together, this study provided evidence for the
autoimmune nature of AA and evidence in support of a Th1
immune reaction, which apparently becomes chronic in
AA-susceptible mice, but will become downregulated in AA-re-
sistant mice. The results demonstrate that the principle of
promoting resistance to AA onset in genetically susceptible, but
immunologically naive mice is possible. As AA has the tendency
to wax and wane in both human and rodent models, it is
particularly noteworthy that resistance to AA development was a
relatively constant feature as revealed by repeated skin grafting of
resistant mice with AA-a¡ected skin. The stability of AA resis-
tance will help to elucidate the underlying mechanism and will
provide hints for new therapeutic targets. Full elucidation of
the active mechanisms of resistance to AA in mice may de¢ne
a method for the permanent inhibition of AA in susceptible
individuals.
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